T.R. is a co-founder, shareholder, and employee of Akero Therapeutics and shareholder of Pfizer. Akero Therapeutics has licensed exclusive rights to patents relating to AKR-001’s composition and use. Supplemental Information Download all supplementary files included with this articleWhat’s this?
doi:10.1208/s12248-019-0356-4Fengping LiPfizer Inc.Yan WengPfizer Inc.Guodong ZhangPfizer Inc.Xiaogang HanPfizer Inc.Dongmei LiPfizer Inc.Hendrik NeubertPfizer Inc.Springer International PublishingThe AAPS Journal